US2020308253A1PendingUtilityA1
Single alpha chain collagens
Est. expiryOct 18, 2037(~11.2 yrs left)· nominal 20-yr term from priority
A61K 38/39B32B 5/024B32B 2307/306B32B 2262/101B32B 2255/02C07K 14/78B32B 2255/26B32B 5/06B32B 5/022B32B 5/26B32B 2307/7265B32B 2262/10B32B 2571/00B32B 2307/3065B01D 2311/02B01D 61/32B01D 61/243C07K 1/34B01D 2311/18B01D 2317/022
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a method for the production of single alpha chain collagens and an isolated or purified product comprising single alpha chain collagens.
Claims
exact text as granted — not AI-modified1 . Isolated single alpha chain collagens (SACCs) in aqueous solution wherein said SAC is or has:
a) a single chain polypeptide existing as an alpha helix and having a molecular weight of approximately 100 kDa; b) a repeating sub structure of Glycine-X-Y (where X can be any amino acid, and Y is proline or hydroxyproline); and c) non-helical N-terminal and/or C-terminal ends; and further wherein said aqueous solution does not include gamma collagen.
2 . The isolated SACCs according to claim 1 wherein said aqueous solution does not include beta collagen.
3 . The isolated SACCs according to claim 1 , wherein said aqueous solution contains an amount of SACCs per total collagen protein content of at least 50%, 75%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100%.
4 . The isolated SACCs according to claim 1 , wherein said aqueous solution comprises SACCs at a concentration of at least 20% w/v.
5 . The isolated SACCs according to claim 1 , wherein said SACCs are of mammalian or cnidarian origin.
6 . The isolated SACCs according to claim 5 wherein said SACCs are of bovine porcine, equine, or jellyfish origin.
7 . The isolated SACCs according to claim 1 , wherein said SACCs are recombinant or of recombinant origin.
8 . The isolated SACCs according to claim 1 , wherein each SACC comprises approximately 1000-3500 amino acids.
9 . The isolated SACCs according to claim 8 wherein each SACC comprises approximately 1000-1500 amino acids.
10 . (canceled)
11 . An electrospinning solution comprising the isolated SACCs according to claim 1 and a solution suitable for electrospinning.
12 . A method for producing or purifying single alpha chain collagen (SAC) comprising:
a) obtaining an extraction of collagen in alkaline solution; b) filtering the extraction of collagen in alkaline solution using at least one first filter membrane to produce a first filter retentate; c) adjusting the pH of the first filter retentate so that it is acidic, thereby at least partially solubilising the collagen bound by the first filter retentate; d) filtering the at least partially solubilised first filter retentate using said at least one first filter membrane to produce a second filter retentate; e) adjusting the pH of the second filter retentate so that it is acidic thereby solubilising the collagen bound by the second filter retentate; f) filtering the second filter retentate using at least one second filter membrane to produce a first filtrate comprising SACCs; and g) optionally, filtering the first filtrate using said at least one first filter membrane to produce a second retentate comprising single alpha chain collagen.
13 . The method according to claim 12 , wherein the at least one first filter membrane has a Nominal Molecular Weight Cut-Off (NMWCO) in the range of 1-100,000.
14 . The method according to claim 12 , wherein the at least one first filter membrane has a NMWCO of 10,000 or 50,000.
15 . The method according to claim 12 , wherein the extraction of collagen in alkaline solution in step a) is obtained by treating a collagen-containing sample with alkaline or basic solution to allow cellular matter and other non-collagenous material to be destroyed.
16 . The method according to claim 12 , wherein in step b) the extraction of collagen in alkaline solution is filtered until a pH of less than 8 is achieved and a first filter retentate is obtained.
17 . The method according to claim 12 , wherein in step c) the first filter retentate is adjusted to make a solution having an acidic pH of less than 3.
18 . The method according to claim 12 , wherein in step d) the first filter retentate is filtered until a pH of greater than 6 is achieved.
19 . The method according to claim 12 , wherein in step b) the first filter retentate is supplemented, before during or after filtering, with deionised water and/or in step d) the second filter retentate is supplemented with deionised water.
20 . The method according to claim 12 , wherein steps c)-d) are repeated at least once to improve yield and purity.
21 . The method according to claim 12 , wherein steps c)-d) are performed in a closed circulatory system that either runs constantly or runs constantly during the performance of the said specified steps.
22 . The method according to claim 12 , wherein said filtering in steps b), d), and f) comprises dialysis.
23 . The method according to claim 12 , wherein in step e) the second filter retentate is adjusted to make a solution having a pH of less than 3.
24 . The method according to claim 12 , wherein the at least one second filter membrane is a micro-porous membrane comprising a pore size between about 0.05 to 2 μm and every 0.01 μm integer therebetween.
25 . The method according to claim 12 , wherein in step f) and/or g) the second filter retentate or the first filtrate is/are filtered until a pH of less than 8 is achieved.
26 . The method according to claim 12 , wherein said extraction of collagen is obtained from mammalian or cnidarian tissue.Join the waitlist — get patent alerts
Track US2020308253A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.